Understanding the Infected Blood Scandal: Compensation and Inquiry Findings
In the 1970s and 1980s, over 30,000 people in the UK were infected with HIV and Hepatitis C from contaminated blood. The disaster primarily affected haemophiliacs and blood transfusion patients. Despite repeated warnings, contaminated blood supplies were used until better screening was implemented in 1991. The UK government has paid interim compensation to about 4,000 victims or their partners, with a final compensation plan awaiting the inquiry's report.
In the 1970s and 1980s, over 30,000 people in the UK were infected with HIV and Hepatitis C from contaminated blood products.
Two patient groups were mainly affected: individuals with haemophilia and those who received blood transfusions after medical procedures.
About 1,250 haemophilia patients contracted both diseases, leading to 820 deaths.
Another 2,400 to 5,000 people developed Hepatitis C alone.
A second group of around 27,000 patients received contaminated transfusions, with 1,640 fatalities from Hepatitis C and 35 from HIV. The tragedy surfaced as the UK relied on US-imported blood plasma, often coming from high-risk donors.
Despite warnings, the NHS continued using these supplies until blood screening improved in 1991.
A public inquiry, initiated in 2017 and led by Sir Brian Langstaff, aims to address this disaster.
So far, interim compensation of one hundred thousand pounds has been paid to about 4,000 living victims or their partners.
The inquiry's final report, expected in 2023, will likely propose a comprehensive compensation scheme, potentially costing billions.
Two patient groups were mainly affected: individuals with haemophilia and those who received blood transfusions after medical procedures.
About 1,250 haemophilia patients contracted both diseases, leading to 820 deaths.
Another 2,400 to 5,000 people developed Hepatitis C alone.
A second group of around 27,000 patients received contaminated transfusions, with 1,640 fatalities from Hepatitis C and 35 from HIV. The tragedy surfaced as the UK relied on US-imported blood plasma, often coming from high-risk donors.
Despite warnings, the NHS continued using these supplies until blood screening improved in 1991.
A public inquiry, initiated in 2017 and led by Sir Brian Langstaff, aims to address this disaster.
So far, interim compensation of one hundred thousand pounds has been paid to about 4,000 living victims or their partners.
The inquiry's final report, expected in 2023, will likely propose a comprehensive compensation scheme, potentially costing billions.
